GRI GRI Bio, Inc.
Healthcare$2.04-0.97%ClosedMarket Cap: $183,257
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.24
P/S
0.00
EV/EBITDA
0.99
DCF Value
$65.28
FCF Yield
-6559.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-199.5%
ROA
-96.2%
ROIC
-103.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.0M | $-2.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.7M | $-2.7M | $— | — |
| Q4 2025 | $0.00 | -Infinity% | $-2.7M | $-2.7M | $-5.34 | — |
| FY null | $0.00 | NaN% | $-12.0M | $-12.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.4M | $-3.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.9M | $-2.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.1M | $-3.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.0M | $-1.9M | $— | — |
| FY null | $22.5M | -0.0% | $-8.2M | $-8.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-2.1M | $-2.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.3M | $-2.3M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.9M | $-1.9M | $— | — |